Maija Saraste

Serum glial fibrillary acid protein associates with TSPO-expressing lesions in multiple sclerosis brain (2025)

Sjöros, Tanja; Saraste, Maija; Matilainen, Markus; Nylund, Marjo; Koivumäki, Mikko; Kuhle, Jens; Leppert, David; Airas, Laura

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Plasma CHI3L1 associates with brain volume loss and glial activation in multiple sclerosis (2025)

Journal of Neurology, Neurosurgery and Psychiatry

Ahola, Venla; Saraste, Maija; Nylund, Marjo; Matilainen, Markus; Luoma, Amelie; Vuorimaa, Anna; Lehto, Jussi; Laaksonen, Sini; Brockmann, Eeva-Christine; Kuhle, Jens; Leppert, David; Soukka, Tero; Lamminmäki, Urpo; Airas, Laura

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Predictors of risk of secondary progression in multiple sclerosis (2025)

Therapeutic Advances in Neurological Disorders

Laaksonen, Sini; Sucksdorff, Marcus; Vuorimaa, Anna; Kuhle, Jens; Nylund, Marjo; Rajander, Johan; Wahlroos, Saara; Matilainen, Markus; Saraste, Maija; Airas, Laura

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Multiple sclerosis: 2024 update (2025)

Free Neuropathology

Klotz, Luisa; Saraste, Maija; Airas, Laura; Kuhlmann, Tanja

(A2 Vertaisarvioitu katsausartikkeli tieteellisessä lehdessä)

TSPO-PET-measurable microglial activity remains unaltered in cladribine-treated RRMS patients (2024)

The European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), Multiple Sclerosis

Rajalehto, Olli; Saraste, Maija; Matilainen, Markus; Nylund, Marjo; Honkonen, Eveliina; Lehto, Jussi; Airas, Laura

(Konferenssiposteri)

Sex-driven variability in TSPO-expressing microglia in MS patients and healthy individuals (2024)

Frontiers in Neurology

Laaksonen Sini, Saraste Maija, Nylund Marjo, Hinz Rainer, Snellman Anniina, Rinne Juha, Matilainen Markus, Airas Laura

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

A Novel Comprehensive Epigenomic Liquid Biopsy Assay Reveals Disease Biology in Multiple Sclerosis Patients from 1 mL of Plasma (2024)

Multiple Sclerosis

Beagan, Jonathan; Nylund, Marjo; Painter, Corrie; Saraste, Maija; Chmielecki, Juliann; Tran, Vy; Tamakloe, Tyrone; Matilainen, Markus; Eaton, Matthew; Barrett, Carl; Airas, Laura

(Abstrakti)

Plasma CHI3L1 associates with increased TSPO-PET measurable microglial activation in patients with progressive multiple sclerosis (2024)

Congress of the European Committee for Treatment and Research in Multiple Sclerosis, Multiple Sclerosis

Ahola, Venla; Saraste, Maija; Matilainen, Markus; Brockmann, Eeva-Christine; Lamminmaki, Urpo; Airas, Laura

(Konferenssiposteri)

Early prognosticators of later TSPO-PET-measurable microglial activation in multiple sclerosis (2023)

Multiple Sclerosis and Related Disorders

Laaksonen Satu, Saraste Maija, Sucksdorff Marcus, Nylund Marjo, Vuorimaa Anna, Matilainen Markus, Heikkinen Jaakko, Airas Laura

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Association of serum neurofilament light with microglial activation in multiple sclerosis (2023)

Journal of Neurology, Neurosurgery and Psychiatry

Saraste Maija, Matilainen Markus, Vuorimaa Anna, Laaksonen Sini, Sucksdorff Marcus, Leppert David, Kuhle Jens, Airas Laura

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Maija

Saraste

Ota yhteyttä

Julkaisut

Järjestä:

Serum glial fibrillary acid protein associates with TSPO-expressing lesions in multiple sclerosis brain (2025)

Plasma CHI3L1 associates with brain volume loss and glial activation in multiple sclerosis (2025)

Predictors of risk of secondary progression in multiple sclerosis (2025)

Multiple sclerosis: 2024 update (2025)

TSPO-PET-measurable microglial activity remains unaltered in cladribine-treated RRMS patients (2024)

Sex-driven variability in TSPO-expressing microglia in MS patients and healthy individuals (2024)

A Novel Comprehensive Epigenomic Liquid Biopsy Assay Reveals Disease Biology in Multiple Sclerosis Patients from 1 mL of Plasma (2024)

Plasma CHI3L1 associates with increased TSPO-PET measurable microglial activation in patients with progressive multiple sclerosis (2024)

Early prognosticators of later TSPO-PET-measurable microglial activation in multiple sclerosis (2023)

Association of serum neurofilament light with microglial activation in multiple sclerosis (2023)